Prescription drug · UNAPPROVED DRUG OTHER
Mb Caps NDC 28595-299
Methenamine 120 mg/1 + 4 more ingredients · Capsule · Oral · Allegis Pharmaceuticals, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 28595-299-60 | 28595029960 | 60 CAPSULE in 1 BOTTLE (28595-299-60)Marketed from Feb 25, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Mb Caps
- Generic name (nonproprietary)
- methenamine, sodium phosphate, monobasic, monohydrate, phenyl salicylate, methylene blue, and hyoscyamine sulfate
- Active ingredients
- Methenamine — 120 mg/1Sodium phosphate, Monobasic, Monohydrate — 40.8 mg/1Phenyl salicylate — 36.2 mg/1Methylene blue — 10.8 mg/1Hyoscyamine sulfate — .12 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- Allegis Pharmaceuticals, LLC
- Product type
- Prescription drug
- Marketing category
- Unapproved drug (other)
- Marketing start
- Listing expires
- Other FDA classes
- Oxidation-Reduction Activity (Mechanism)
- Identifiers
- Product ID 28595-299_2efeb5ff-bd09-a444-e063-6294a90a8581SPL ID 2efeb5ff-bd09-a444-e063-6294a90a8581SPL set ID 2efeb281-b84b-4750-e063-6394a90a27eeRxCUI 2637557UNII J50OIX95QV, 593YOG76RN, 28A37T47QO, T42P99266K, F2R8V82B84
- Pharmacologic class
- Oxidation-Reduction Agent
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N428595029960followed by a unit qualifier and the quantityPackage 28595-0299-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE MB CAPS is indicated for the treatment of symptoms of irritative voiding. Indicated for the relief of local symptoms, such as inflammation, hypermotility, and pain, which accompany lower urinary tract infections. Indicated for the relief of urinary tract symptoms caused by diagnostic procedures.
Excerpt only. Read the full label for complete information.